Cell Source, Inc. (CLCS) Operating cash flow 2015–2024
Cell Source, Inc. (CLCS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.7MFY2024 · since FY2015: -$2.0M → -$2.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.7M | -14.3% |
| FY2023 | -$2.3M | +25.2% |
| FY2022 | -$3.1M | +7.1% |
| FY2021 | -$3.4M | -21.8% |
| FY2020 | -$2.8M | -7.2% |
| FY2019 | -$2.6M | -29.2% |
| FY2018 | -$2.0M | +12.5% |
| FY2017 | -$2.3M | -53.1% |
| FY2016 | -$1.5M | +25.3% |
| FY2015 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLCS financial trends
CLCS RevenueCLCS Net incomeCLCS Net marginCLCS Gross profitCLCS Gross marginCLCS Operating incomeCLCS Operating marginCLCS Free cash flowCLCS Capital expendituresCLCS Return on equityCLCS Stock buybacksCLCS Dividends paidCLCS Total assetsCLCS Total liabilitiesCLCS Shareholders’ equityCLCS overview →